In the BioHarmony Drug Report Database

"Preview" Icon

Methdilazine

Tacaryl (methdilazine) is a small molecule pharmaceutical. Methdilazine was first approved as Tacaryl on 1982-01-01. It is used to treat allergic contact dermatitis, allergic rhinitis perennial, atopic dermatitis, eczema, and pityriasis rosea amongst others in the USA.

 

Trade Name

 

Tacaryl
 

Common Name

 

methdilazine
 

ChEMBL ID

 

CHEMBL1200959
 

Indication

 

allergic contact dermatitis, allergic rhinitis perennial, atopic dermatitis, eczema, pityriasis rosea, urticaria
 

Drug Class

 

Vasodilators (undefined group); antiarrhythmic/antianginal/antihypertensive agents, phthalazine like structure

Image (chem structure or protein)

Methdilazine structure rendering